Download Michael Castro, MD - caris

Michael Castro, MD
Senior Medical Director
E D U C AT I O N
1986 M.D.
Columbia – College of Physicians and Surgeons
1982 PreMed
Harvard University and Brandeis University
1979 B.A.
Brandeis University
POSTDOCTORAL TRAINING
1994
Post Graduate in Biochemotherapy
of Renal Cell Carcinoma and Melanoma
MD Anderson Cancer Center, Houston, Texas
1989-1991
Fellow, Neoplastic Diseases
Mt. Sinai Medical Center, New York, New York
1986-1989
Resident, Internal Medicine
St. Lukes – Roosevelt Hospital, New York, New York
CURRENT PRACTICE
2012 - Present Personalized Cancer Medicine, PLLC
Honolulu, Hawaii
C E R T I F I C AT I O N
American Board of Internal Medicine
American Board of Medical Oncology
NIH Certification of Human Subjects Research
ACADEMIC APPOINTMENTS
2001 - Present
Clinical Associate Professor of Medicine
University of Vermont, Burlington, Vermont
PROFESSIONAL SOCIETIES
American Society of Clinical Oncology
American Medical Association
S E L E C T P U B L I C AT I O N S
Pharmacokinteics Of Bsi-201, A Poly (Adp-Ribose)
Polymerase-1 (Parp1) Inhibitor In Cerebrospinal Fluid Of A
Breast Cancer Patient With Carcinomatous Meningitis.
M Castro, L Li, Te Stallings. Proc Am Soc Clin Oncol 2010,
Abstract 48374
Peripheral Sensory Neuropathy - Fighting Cold With Cold.
Castro Mp Lancet Oncol 2008 9:415-6
Pharmacogenetics In The Clinic: The New Questions About
Tamoxifen. Castro Mp. J Oncol Prac 2006 2:100
Resisting A Fundamentalist Philosophy. M Castro J Clin Oncol
2005 23:3645-46
Bisphosphonate-Induced Osteosclerosis In A Breast Cancer
Patient. Castro Mp, Novak S, Whyte Mp. J Bone & Mineral Res
2005
Pharmacogenetic Correlates Of Benefit From Gemcitabine And
Platinum In Patients With Advanced Bladder Cancer. M Castro,
A Neumann, M Konichexky, K Dannenberg, S Stemmer Proc
Am Soc Clin Oncol 2004 Abstract 3203
Thymidine Rescue: An Antidote For Pemetrexed Related
Toxicity In The Setting Of Acute Renal Failure, M. Castro, J Clin
Oncol 2003, 21:4066
Targeted Therapy. M. Castro In Heme-Onc Secrets Ed. M.
Wood. University Of Vermont Press 2003.
Timing Is Everything Or Could Be. M. Castro J Clin Oncol 21:
755, 2003.
The Simpleton’s Error In Drug Development. M. Castro. J Clin
Oncol 2002 20: 4606-7.
Successful Use Of Anti-Cd20 Monoclonal Antibody, Rituxan,
In Patients With Non-Hodgkin’s Lymphoma And Renal
Insufficiency. Castro Mp, Vanauken J, Sponzo Rw. Proc. Am Soc
Clin Oncol 2001, 20:3325.
Cerebrospinal Fluid Gastrin-Releasing Peptide In The Diagnosis
Of Leptomeningeal Metastases In Small Cell Carcinoma.
Mp Castro, S Qualman, T Odorisio, Cancer 2001, 91:2122-2126.
Cyclophosphamide, 5-Fluorouracil And Prednisone (Cfp) In
Hormone Refractory Prostate Cancer. Mp Castro, J Vanauken,
N Oberhelman, Rw Sponzo. Proc Am Soc Clin Oncol. 2000,
19:1435,.
The Impact Of Risk Stratification Of Mammographic
Interpretation. R Sponzo, T Ashikaga, C Howland, P Cisek,
Mp Castro. Proc Am Soc Clin Oncol 2000, 19:335.
Have The Recently Completed Phase Iii Trials Significantly
Impacted Adjuvant Treatment Choices For Stage Ii Breast
Carcinoma? Middleman E, Castro Mp, Gradishar W. Semin
Oncol, 1999, 26(4): Xvi, Xvii-Xx,.
Acute Tumor Lysis Syndrome Associated With Concurrent
Biochemotherapy Of Metastatic Melanoma: A Case Report And
Review Of The Literature. Castro Mp, S Legha, J Van Auken, P
Cisek, Rw Sponzo. Cancer 1999 85(5): 1055-9.
Efficacy Of Gemcitabine In The Treatment Of Patients With
Gallbladder Carcinoma; A Case Report. M. Castro, Cancer 1998,
82(4): 639-41.
Clinicopathologic Correlations With Mucin Carbohydrate
Antigen Expression In Breast Cancer. M. Castro, J. Strauchen,
J. Mandeli, R. Perles, J. Morrison, S. Itzkowitz. Proc Am Soc Clin
Oncol, 1991 10:200.
Eniluracil’s Need For A Targeted Approach: A Lesson In Drug
Development. M Castro. J Clin Oncol 2002 20: 3750.
Ex-Vivo Apoptotic Assay (Eva)-Directed Use Of Gemcitabine As
Salvage Therapy In Colorectal Carcinoma: Case Report.
M Castro. Lilly Oncology Investigators Meeting. April 4, 2002
To order Caris Molecular Intelligence Services or
to speak with a Caris Life Sciences’ representative, call
(888) 979-8669
or visit us online at www.CarisMolecularIntelligence.com.
© 2013 Caris Life Sciences and affiliates. All rights reserved. TN0103 1.13